Here, we focus on Siglec‐XII expression in tumor and normal epithelia, identify genes upregulated upon Siglec‐XII expression, address the predictive value of SIGLEC12 status in cancer cohorts, and provide further evidence suggesting ongoing selection for the null state. Here, SIGLEC12 is linked to cancer.